Some Doctors Voice Concerns About Safety, Risks of Rx Weed
The Fred Hutchinson Cancer Research Center in Seattle WA, publishes a newsletter that is quite informative. It is called, “Hutch News.” They publish news about their research on cancer and a host of other diseases, including: Myelodysplastic Syndrome (MDS) from which my late husband suffered; Multiple Sclerosis (MS); HIV/AIDS; and many others.
This latest article was interesting in that it was the first one that I’ve come across which details a good reason why perspective users of medical marijuana should beware.
Mold is a very real possibility.
The article contains stories and opinions of patients who use medical marijuana to help relieve their pain and discomfort from chemotherapy; however, I got the impression, from reading the article, that a possibility of mold infection was very low on the scale of possible side effects.
High on the scale of course, was the patients’ feelings of well-being and relief from the discomfort they experienced. They were able to go on with their daily activities without the pain and other effects from cancer treatments.
Questions … and more questions
“Legalization has changed the conversation. When somebody asks me: ‘Did you vote for the [Washington] marijuana law?’ I say I did because I don’t think it’s something that needs to be super regulated,” Pergam added “But I think we need to use it judiciously. The question really is: How do you do that while protecting patients and then giving them access to the potential benefits that there may be?
“I want to understand the use patterns so I can give people constructive advice. If patients wanted to use it, what are the best ways to be protected? But I don’t think we know any of this data yet.”
That absence of evidence is due to the federal classification of marijuana as a Schedule 1 substance along with heroin and LSD. Drugs in Schedule 1 have “no currently accepted medical use,” U.S. authorities assert. Marijuana also remains federally illegal.
The designation essentially creates a federal monopoly on the marijuana that researchers need to study the plant’s medical potential. There is one U.S.-sanctioned pot garden — at the University of Mississippi. It’s managed by the National Institute on Drug Abuse and produces the only cannabis that’s available for federally sanctioned marijuana studies.
So, what does that leave doctors who want to answer their patients’ pot questions? Mostly: More questions.
[ Header image from http://www.freewebheaders.com ]